Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New drugs for tuberculosis

C Grassi1, V Peona

  • 1Institute of Respiratory Diseases, Pavia. Italy.

The European Respiratory Journal. Supplement
|September 1, 1995
PubMed
Summary
This summary is machine-generated.

New antibiotics are needed to combat drug-resistant tuberculosis (TB). Rifabutin and fluoroquinolones show promise, offering effective treatments against multidrug-resistant TB strains.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ventral striatal neuroimmune signalling biases the expression of social memory in male mice.

Brain, behavior, and immunity·2026
Same author

HSV-1 infection induces phosphorylated tau propagation among neurons via extracellular vesicles.

mBio·2024
Same author

Combined molecular and mathematical analysis of long noncoding RNAs expression in fine needle aspiration biopsies as novel tool for early diagnosis of thyroid cancer.

Endocrine·2020
Same author

Neural functional correlates of emotional processing in patients with first-episode psychoses: an activation likelihood estimation (ALE) meta-analysis.

Archives italiennes de biologie·2018
Same author

Afit: a bioinformatic tool for measuring aphid fitness and invasiveness.

Bulletin of entomological research·2016
Same author

Styrene enhances the noise induced oxidative stress in the cochlea and affects differently mechanosensory and supporting cells.

Free radical biology & medicine·2016
Same journal

Current status of lung transplantation.

The European respiratory journal. Supplement·2003
Same journal

Treatment of chronic respiratory failure: lung volume reduction surgery versus rehabilitation.

The European respiratory journal. Supplement·2003
Same journal

Home ventilation.

The European respiratory journal. Supplement·2003
Same journal

Mechanical ventilation: invasive versus noninvasive.

The European respiratory journal. Supplement·2003
Same journal

Respiratory failure in chronic obstructive pulmonary disease.

The European respiratory journal. Supplement·2003
Same journal

Physical and biological triggers of ventilator-induced lung injury and its prevention.

The European respiratory journal. Supplement·2003
See all related articles

Area of Science:

  • Microbiology
  • Pharmacology
  • Infectious Diseases

Background:

  • Tuberculosis treatment has relied on antibiotics since the 1960s.
  • Short-course antibiotic regimens (isoniazid, rifampin, plus others) have been standard.
  • Rising drug-resistant Mycobacterium tuberculosis strains necessitate novel therapeutic agents.

Purpose of the Study:

  • To review the efficacy of emerging drugs against tuberculosis.
  • To identify new therapeutic options for multidrug-resistant tuberculosis (MDR-TB).

Main Methods:

  • In vitro and animal model studies were reviewed.
  • Clinical efficacy of new drug candidates was assessed.
  • Drug resistance patterns and cross-resistance were evaluated.

Related Experiment Videos

Main Results:

  • Rifabutin demonstrates higher in vitro activity than rifampin and is effective against MDR-TB.
  • Fluoroquinolones (e.g., ofloxacin, ciprofloxacin) show antimycobacterial activity and synergy with existing drugs.
  • Rifapentine is potent but not effective against rifampin-resistant strains.
  • Other agents like paromomycin and a novel nitroimidazole exhibit in vitro activity.

Conclusions:

  • New rifamycin derivatives and fluoroquinolones represent promising avenues for TB treatment.
  • Development of novel antibiotics is crucial to overcome resistance challenges in tuberculosis therapy.